Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Alpha, 13-Cis-Retinoic Acid, and Paclitaxel in Recurrent Small Cell Lung Cancer
NCT00062010Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- May 2004
- Primary completion
- May 2011
- Modality
- Cytokines & Interferons, Small Molecules, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa, isotretinoin, Paclitaxel Micelles for Injection in small cell lung cancer (SCLC), sponsored by Eastern Cooperative Oncology Group. Started May 2004; status: completed.
02
Drugs
interferon alfaisotretinoinPaclitaxel Micelles for Injection
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00062010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00062010.